These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6454713)

  • 1. Bromocriptine and imipramine in endogenous depression. A double-blind controlled trial in out-patients.
    Waehrens J; Gerlach J
    J Affect Disord; 1981 Jun; 3(2):193-202. PubMed ID: 6454713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine in depression.
    Bouras N; Bridges PK
    Curr Med Res Opin; 1982; 8(3):150-3. PubMed ID: 7128188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind controlled clinical trial comparing fluvoxamine with imipramine.
    Guelfi JD; Dreyfus JF; Pichot P
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):411S-417S. PubMed ID: 6407501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter double-blind comparison of nomifensine and imipramine for efficacy and safety in depressed outpatients.
    Bremner JD; Abrahams LM; Crupie JE; McCawley A; Proctor RC; Sathananthan GL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):56-9. PubMed ID: 6370976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-center double-blind study of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Cohn JB; Varga L; Lyford A
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):68-72. PubMed ID: 6370980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative, multicenter trial between bromocriptine and amitriptyline in the treatment of endogenous depression.
    Theohar C; Fischer-Cornelssen K; Brosch H; Fischer EK; Petrovic D
    Arzneimittelforschung; 1982; 32(7):783-7. PubMed ID: 6751339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An outpatient evaluation of phenelzine and imipramine.
    Davidson J; Raft D; Pelton S
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre double-blind comparative trial of zimeldine and imipramine in primary major depressive disorders.
    Hiramatsu KI; Takahashi R; Mori A; Inoue R; Kazamatsuri H; Murasaki M; Sakuma A
    Acta Psychiatr Scand Suppl; 1983; 308():41-54. PubMed ID: 6230895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
    Cohn JB; Wilcox C
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):26-31. PubMed ID: 3882677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression.
    Itil TM; Shrivastava RK; Mukherjee S; Coleman BS; Michael ST
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):433S-438S. PubMed ID: 6407504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
    McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
    J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled study of trazodone, imipramine, and placebo in outpatients with endogenous depression.
    Mann JJ; Georgotas A; Newton R; Gershon S
    J Clin Psychopharmacol; 1981 Mar; 1(2):75-80. PubMed ID: 7028798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomifensine and imipramine in endogenous depression. A double-blind Scandinavian multicentre study.
    Dencker SJ; Lundin L; Jensen K; Klitgaard NA; Wraae O; Eggert Hansen C; Ahlfors UG; Tuomikoski S; Pihkanen T; Jorgensen HA; Ose E
    Int Pharmacopsychiatry; 1982; 17 Suppl 1():116-44. PubMed ID: 6752078
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluoxetine in depressed patients: a comparison with imipramine.
    Bremner JD
    J Clin Psychiatry; 1984 Oct; 45(10):414-9. PubMed ID: 6384203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives.
    Guy W; Ban TA; McEvoy JP; Petrie WM; Wilson WH; Schaffer JD
    Int Pharmacopsychiatry; 1982; 17(1):36-42. PubMed ID: 7045017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, controlled evaluation of zimeldine, imipramine and placebo in patients with primary affective disorders.
    Merideth CH; Feighner JP
    Acta Psychiatr Scand Suppl; 1983; 308():70-9. PubMed ID: 6230897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.